The Libin Cardiovascular Institute is a joint entity of Alberta Health Services and the University of Calgary. Our more than 1,500 members include physicians, clinicians and other health professionals, researchers and trainees.
Our Initiatives
Cardiovascular disease is the No. 1 cause of premature death globally. The Libin Cardiovascular Institute is tackling these problems head on through world-class cardiovascular research, training and clinical care.
The Libin Cardiovascular Institute’s four initiatives are at the heart of this work. They drive our research and ultimately enable us in our mission to improve cardiovascular outcomes for Albertans at all ages and stages of life.
Precision Medicine Initiative
Our goal is to spark innovation to navigate the complexities of the human system so we can predict and prevent disease and provide more personalized care
Learn how the Libin Cardiovascular Institute is transforming health care
Clinical Innovation Initiative
Our goal is to provide patients with tomorrow’s health care today by accelerating the speed of health care innovation and implementation
Learn how the Libin Cardiovascular Institute is improving patient care
P2 Initiative
Our goal is to engage communities to help us identify, study and address the challenges impacting health
Learn how the Libin Cardiovascular Institute is improving cardiovascular health in our communities
Women's Cardiovascular Health Initiative
Our goal is to improve the odds for women locally and globally by closing the gap in cardiovascular research, training and care
Learn how the Libin Cardiovascular Institute is advancing women’s cardiovascular health
Latest news
Aaron Phillips receives prestigious ‘Gairdner Momentum Award’
National honour goes to mid-career researcher for exceptional scientific contribution to human health
Researchers discover potential new pathway to heart repair and to prevent heart failure
UCalgary study reveals immune cells that protect the heart from excessive scarring after a heart attack
Nurse fighting against cardiac amyloidosis
Jan Veenhuyzen at the forefront of improving patient outcomes
Globally recognized expert joins the Libin Cardiovascular Institute
Dr. Rahul Chanchlani aims to improve and protect heart and kidney health